1991
DOI: 10.1016/0026-0495(91)90109-a
|View full text |Cite
|
Sign up to set email alerts
|

Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(25 citation statements)
references
References 38 publications
1
24
0
Order By: Relevance
“…In line with this Cummings et al [9] observed no effect of insulin on VLDL apo B FCR in NIDDM subjects. In conclusion, we have uncovered an action of insulin on VLDL1 apo B metabolism in vivo that was postulated to occur on the basis of cell culture findings [29,30]. Teleologically, an acute action of insulin on the release of large triglyceride-rich lipoproteins from the liver helps preserve hepatic lipid stores at a time when there is abundant triglyceride present in the circulation in the form of chylomicrons i. e. it is a further 'anabolic' action of the hormone.…”
Section: Discussionmentioning
confidence: 86%
See 2 more Smart Citations
“…In line with this Cummings et al [9] observed no effect of insulin on VLDL apo B FCR in NIDDM subjects. In conclusion, we have uncovered an action of insulin on VLDL1 apo B metabolism in vivo that was postulated to occur on the basis of cell culture findings [29,30]. Teleologically, an acute action of insulin on the release of large triglyceride-rich lipoproteins from the liver helps preserve hepatic lipid stores at a time when there is abundant triglyceride present in the circulation in the form of chylomicrons i. e. it is a further 'anabolic' action of the hormone.…”
Section: Discussionmentioning
confidence: 86%
“…However, more recent cell culture work has provided clear evidence that the presence of insulin has 1 507 326 269 507 326 269 188 108 210 2 1086 1011 883 1086 1011 883 201 201 364 3 687 792 870 687 792 870 175 155 166 4 500 510 331 483 492 311 191 179 230 5 904 842 356 796 116 72 6 690 625 747 690 625 747 140 106 an inhibitory effect on VLDL synthesis and release [29,30]. Comparable investigations in humans have reported discrepant results.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, genetic disruption of hepatic insulin signaling in mice reduces triglyceride secretion, lowers serum TAG levels, and reduces atherogenesis in animal models (8)(9)(10). On the other hand, in isolated hepatocytes, insulin treatment inhibits VLDL-TAG and apolipoprotein B secretion (11,12). Therefore, there are conflicting reports on the role of hepatic insulin signaling in the control of VLDL secretion.…”
Section: Introductionmentioning
confidence: 99%
“…One possible mechanism to account for the lower postprandial change in overall total TAG concentration following lunch compared to breakfast is suppression of VLDL-TAG secretion by the liver. This is supported by the observation that addition of insulin to cultured cells (Durrington et al, 1982;Dashti & Wolfbauer, 1987;Sparks et al, 1989;Byrne et al, 1991;Salhanick et al, 1991) and acute hyperinsulinaemia in human subjects (Vogelberg et al, 1978;Lewis et al, 1993Lewis et al, , 1994Shumak et al, 1988;Malmstrom et al, 1997a) suppressed VLDL secretion. Furthermore, Malmstrom et al (1998) showed that hyperinsulinaemia suppressed secretion of VLDL 1 leading to a differential increase in VLDL 2 secretion.…”
Section: Discussionmentioning
confidence: 85%